Tobacco endgame: twenty years of international and Russian experience. Part I. Policies, strategies, and measures to end the tobacco epidemic: product and consumerfocused initiatives
https://doi.org/10.15829/1728-8800-2025-4487
EDN: GMDBRC
Abstract
More and more countries are implementing strategies aimed at ending the tobacco epidemic. The aim of this three-article study was to analyze existing tobacco endgame strategies and measures, their potential or actual effectiveness, assess the implementation of these strategies within national legislation, identify the main barriers to their implementation, and discuss prospects for achieving them. This article systematizes tobacco endgame policy initiatives, strategies, and measures, as well as analyzes productand consumer-focused policy initiatives, the strategies and measures implemented within these initiatives, and their effectiveness.
About the Authors
M. G. Gambaryan
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Petroverigsky Lane, 10, bld. 3, Moscow, 101990
O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Petroverigsky Lane, 10, bld. 3, Moscow, 101990
References
1. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. Prevention of chronic noncommunicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. (In Russ.) doi:10.15829/1728880020223235.
2. Dolgalev IV, Ivanova AYu, Karpov RS. Predictive value of cardiovascular risk factors in the formation of cardiovascular and allcause mortality: results of a 27year cohort prospective study. Russian Journal of Cardiology. 2023;28(2):5045. (In Russ.) doi:10.15829/1560407120235045.
3. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the noncommunicable disease crisis. Lancet. 2011;377(9775):143847. doi:10.1016/S01406736(11)603930.
4. Khaltaev NG, Axelrod SV. How to achieve the UN Sustainable Development Goals in the field of noncommunicable diseases by 2030, according to research in 49 countries. Public Health. 2021;1(3):1325. (In Russ.) doi:10.21045/278216762021131325.
5. Berrick AJ. The tobaccofree generation proposal. Tob Control. 2013;22(suppl 1):i22i26. doi:10.1136/tobaccocontrol2012050865.
6. ChungHall J, Craig L, Gravely S, et al. Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group. Tob Control. 2019;28(suppl 2):s11928. doi:10.1136/tobaccocontrol2018054389.
7. Drapkina OM, Maksimov SA, Shalnova SA, et al. Prevalence of smoking and its changes over time In Russia: data from the ESSERF study. Cardiovascular Therapy and Prevention. 2023;22(8S):3790. (In Russ.). doi:10.15829/1728880020233790.
8. Gambarian MG. The whole truth of electronic cigarettes: the Russian reality. Part I. Electronic cigarettes a threat to people and Tobacco control policy In Russia. Urgency for legal regulation. Russian Journal of Preventive Medicine. 2019;22(5):715. (In Russ.) doi:10.17116/profmed2019220517.
9. Podzolkov VI, Bragina AE, Druzhinina NA, Mohammadi LN. Ecigarette Smoking (Vaping) and Markers of Vascular Wall Damage in Young Subjects without Cardiovascular Disease. Rational Pharmacotherapy in Cardiology. 2021;17(4):5217. (In Russ.) Пdoi:10.20996/1819644620210804.
10. Gambarian MG, Kalinina AM, Popovich MV, et al. The whole truth of Electronic cigarettes: the Russian reality. Part II. Use of Electronic cigarettes In Russia: associations with demographic factors, advertisement and promotion, tobacco smoking and quit smoking attempts. Results from adult population representative survey EPOCHARF. Russian Journal of Preventive Medicine. 2019;22(6):1427. (In Russ.) doi:10.17116/profmed20192206214.
11. Gambarian MG, Kalinina AM, Popovich MV, et al. The whole truth of Electronic cigarettes: the Russian reality. Part III. Support for legal regulations of Electronic cigarettes. Results from adult population representative survey EPOCHARF. Russian Journal of Preventive Medicine. 2020;23(1):2334. (In Russ.) . doi:10.17116/profmed20202301123.
12. Gambaryan MG. Legislative regulation of new nicotinecontaining products in the world: measures of the global control. Russian Journal of Preventive Medicine. 2022;25(9):2432. (In Russ.) doi:10.17116/profmed20222509124.
13. González Marrón A, Koprivnikar H, Tisza J, et al. Tobacco endgame in the WHO European Region: Feasibility in light of current tobacco control status. Tobacco Induced Diseases. Tob Induc. Dis. 2023;21:116. doi:10.18332/tid/174360.
14. Gambaryan MG, Drapkina OM. Impact of implementation of Tobacco control legislative measures on smoking prevalence in 10 Russian Federal Subjects from 2013 to 2018. Russian Journal of Preventive Medicine. 2021;24(2):4451. (In Russ.) doi:10.17116/profmed20212402144.
15. Gambaryan MG, Kontsevaya AV, Agishina TA, Drapkina OM. Effectiveness of legislative actions against tobacco smoking regarding the reduction of inhospital morbidity of angina pectoris and myocardial infarction In Russia as a whole and 10 Russian constituent entities. Cardiovascular Therapy and Prevention. 2021;20(6):2911. (In Russ.) doi:10.15829/1728880020212911.
16. McDaniel PA, Smith EA, Malone RE. The tobacco endgame: a qualitative review and synthesis. Tob Control. 2016;25(5):594604. doi:10.1136/tobaccocontrol2015052356.
17. van der Eijk Y. Development of an integrated tobacco endgame strategy. Tob Control. 2015;24(4):33640. doi:10.1136/tobaccocontrol2013051211.
18. Ruokolainen O, Ollila H, Laatikainen T, et al. Tobacco endgame measures and their adaptation in selected European countries: A narrative review synthesis. Tob Prev Cessat. 2024;10:116. doi:10.18332/tpc/186402.
19. Kong AY, Henriksen L. Retail endgame strategies: Reduce tobacco availability and visibility and promote health equity. Tob Control. 2022;31(2):2439. doi:10.1136/tobaccocontrol2021056555.
20. Puljević C, Coomber K, de Andrade D, et al. Closing the gaps in tobacco endgame evidence: a scoping review. Tob Control. 2022;31(2):36575. doi:10.1136/tobaccocontrol2021056579.
21. Walker N, Fraser T, Howe C, et al. Abrupt nicotine reduction as an endgame policy: a randomised trial. Tob Control. 2015; 24(e4):e2517. doi:10.1136/tobaccocontrol2014051801.
22. Donny EC, White CM. A review of the evidence on cigarettes with reduced addictiveness potential. Int J Drug Policy. 2022; 99:103436. doi:10.1016/j.drugpo.2021.103436.
23. White CM, Hatsukami DK, Donny EC. Reducing the relative value of cigarettes: Considerations for nicotine and nonnicotine factors. Neuropharmacology. 2020;175:108200. doi:10.1016/j.neuropharm.2020.108200.
24. Brink AL, Glahn AS, Kjaer NT. Tobacco companies’ exploitation of loopholes in the EU ban on menthol cigarettes: a case study from Denmark. Tob Control. 2023;32(6):80912. doi:10.1136/tobaccocontrol2021057213.
25. Pennings JLA, Havermans A, Krüsemann EJZ, et al. Reducing attractiveness of eliquids: proposal for a restrictive list of tobaccorelated flavourings. Tob Control. 2024;33(e1):e417. doi:10.1136/tc2022057764.
26. Ollila H, Ruokolainen O, Laatikainen T, Koprivnikar H. Tobacco endgame goals and measures in Europe: current status and future directions. Tob Control. 2024;tc2024058606. doi:10.1136/tc2024058606.
27. Hill S, Chaiton M, Edwards R. Tobacco Industry "Transformation"– The Current State of Play. Nicotine Tob Res. 2023;25(12):18079. doi:10.1093/ntr/ntad181.
28. Hartwell G, Gilmore AB, van Schalkwyk MC, McKee M. Sunak’s smokefree generation: spare a thought for the tobacco industry. BMJ. 2023;383:2922. doi:10.1136/bmj.p2922.
29. Megina RF, RaduLoghin C, Lozano FR. European Citizens’ Initiative. "Call to achieve a tobaccofree environment and the first European TobaccoFree Generation by 2030". Tob Prev Cessation. 2023;9 (Suppl):A121. doi:10.18332/tpc/162826.
30. Nuyts PAW, Kuipers MAG, Willemsen MC, et al. An Increase in the Tobacco AgeofSale to 21: For Debate in Europe. Nicotine Tob Res. 2020;22(7):12479. doi:10.1093/ntr/ntz135.
31. Friedman AS, Wu RJ. Do Local Tobacco21 Laws Reduce Smoking Among 18 to 20 YearOlds? Nicotine Tob Res. 2020;22(7):1195201. doi:10.1093/ntr/ntz123.
32. Friedman AS, Buckell J, Sindelar JL. Tobacco21 laws and young adult smoking: quasiexperimental evidence. Addiction. 2019; 114(10):181623. doi:10.1111/add.14653.
33. Gambarian MG, Kalinina AM, Popovich MV, et al. Demand for medical smoking cessation support and its implementation: Results from Russian Tobacco control policy evaluation adult populationbased survey EPOCHARF. Russian Journal of Preventive Medicine. 2019;22(4):2636. (In Russ.) doi:10.17116/profmed20192204126.
34. Gambaryan MG, Drapkina OM, Kontsevaya AV, et. al. Monitoring and evaluation of the implementation of tobacco control legislation for protecting people from tobacco smoke exposure and health consequences of tobacco use. Methodical guidelines. Cardiovascular Therapy and Prevention. 2022;21(5):3194. (In Russ.) doi:10.15829/1728880020223194.
Supplementary files
What is already known about the subject?
- The idea of a tobacco endgame is based on tobacco control recognition as the first priority for the prevention of noncommunicable diseases.
- The concept of a tobacco endgame implies a transition to the implementation of policies and strategies aimed at the complete elimination of tobacco use.
What might this study add?
- Policy initiatives, strategies, and measures of a tobacco endgame, as well as country experiences in implementing them, are systematized.
- To achieve tobacco control goals, regulations need to be revised to include product- and consumer-focused measures.
- Comprehensive measures combining several strategies aimed at ending the tobacco epidemic appear to be the most effective.
Review
For citations:
Gambaryan M.G., Drapkina O.M. Tobacco endgame: twenty years of international and Russian experience. Part I. Policies, strategies, and measures to end the tobacco epidemic: product and consumerfocused initiatives. Cardiovascular Therapy and Prevention. 2025;24(9):4487. (In Russ.) https://doi.org/10.15829/1728-8800-2025-4487. EDN: GMDBRC
Views:
110
Email this article 
